Invasive fungal infections are another top concern, as outlined by the World Health Organization’s Fungal Priority Pathogens ...

The modified vaccinia Ankara-Bavarian Nordic mpox vaccine (MVA-BN; Jynneos) generated robust immune responses in adolescents ...

Oral cefixime is a third-generation cephalosporin that has a similar antibacterial spectrum to ceftriaxone. Cefixime is ...

When it was prescribed within a week of SARS CoV-2 infection, metformin was associated with a 53% reduction in long COVID or ...

Clesrovimab, formerly known as MK-1654, is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody.

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent ...

Early antiviral therapy with obeldesivir was safe and well tolerated in patients at high risk for severe COVID-19 and ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

Vaccination for influenza, SARS-CoV-2, and respiratory syncytial virus is less likely with an increasing social vulnerability index and Black race.

(HealthDay News) — Treating hospitalized patients with bloodstream infections with antibiotics for 7 days is noninferior to treating for 14 days, according to a study presented at the annual eeting of ...

The Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine, licensed in the United States to prevent smallpox and mpox, is well tolerated and seems effective in adolescents.